Unlike insulin or other non discretionary drugs, there is a wide gap between the eligible population and the number of people actually on therapy
We saw a recent McKinsey paper that [said] 63 percent of GLP-1 patients who start aesthetics do it for the first time after their weight loss.[According to the] American Society of Plastic Surgeons, 41 percent of patients who are prescribed GLP-1s are considering nonsurgical procedures. Additional research from Circana showed that GLP-1 users overindex in a variety of categories, including beauty
This usually includes dietary changes that can be maintained long term, regular physical activity, attention to sleep, stress management, and treatment of underlying medical conditions
This is why some of the medications can be dosed just once weekly, and why patients benefit from the consistent blood-sugar-lowering and appetite-suppressing effects
Hoping to improve metabolic health while achieving your weight-management goals?
They can interact with: Insulin or sulfonylureas: Risk of low blood sugar
